Close Menu

NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its first quarter revenues were up 64 percent year over year.

The company posted Q1 revenues of $12.3 million, up from $7.5 million in Q1 2018 and above the consensus Wall Street estimate of $10.2 million.

Its Q1 product revenues rose 102 percent to $9.5 million in Q1 2018 from $4.7 million in Q1 2018, with consumables sales up 124 percent and instrument sales up 70 percent. Service and other revenues rose 11 percent to $2.8 million from $2.5 million in the prior-year first quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.